for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Wright Medical Group NV

WMGI.OQ

Latest Trade

20.83USD

Change

-0.39(-1.84%)

Volume

1,039,849

Today's Range

20.77

 - 

21.24

52 Week Range

19.44

 - 

32.82

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
21.22
Open
21.16
Volume
1,039,849
3M AVG Volume
54.94
Today's High
21.24
Today's Low
20.77
52 Week High
32.82
52 Week Low
19.44
Shares Out (MIL)
126.68
Market Cap (MIL)
2,672.91
Forward P/E
125.45
Dividend (Yield %)
--

Next Event

Q3 2019 Wright Medical Group NV Earnings Release

Latest Developments

More

Wright Medical Group NV Q2 Loss Per Share $0.15 From Continuing Operations

Wright Medical Group Reports Q1 Loss Per Share $0.24 From Continuing Operations

Wright Medical Group N.V. Reports Fourth Quarter Results, Provides 2019 Guidance

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Wright Medical Group NV

Wright Medical Group N.V. is a medical device company. The Company is focused on extremities and biologics products. The Company's segments include U.S. Lower Extremities & Biologics, U.S. Upper Extremities and International Extremities & Biologics. Its product portfolio consists of product categories, such as Upper extremities, which includes joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; Lower extremities, which includes joint implants and bone fixation devices for the foot and ankle; Biologics, which includes products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth, and Sports medicine and other, which includes products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries and other ancillary products.

Industry

Medical Equipment & Supplies

Contact Info

Prins Bernhardplein 200

+31.20.6754002

http://www.wright.com/

Executive Leadership

David D. Stevens

Chairman and Independent Non-Executive Director

Robert J. Palmisano

President and Chief Executive Officer and Executive Director

Lance A. Berry

Senior Vice President and Chief Financial Officer

Peter S. Cooke

President, International

Kevin D. Cordell

President, U.S.

Key Stats

1.94 mean rating - 17 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.7K

2017

0.7K

2018

0.8K

2019(E)

0.9K
EPS (USD)

2016

-0.440

2017

-0.220

2018

0.000

2019(E)

0.168
Price To Earnings (TTM)
--
Price To Sales (TTM)
3.00
Price To Book (MRQ)
2.95
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
126.40
LT Debt To Equity (MRQ)
80.28
Return on Investment (TTM)
-5.44
Return on Equity (TTM)
-4.17

Latest News

BRIEF-Wright Medical Group Reports Q1 Loss Per Share $0.19 From Continuing Operations

* WRIGHT MEDICAL GROUP N.V. REPORTS 2018 FIRST QUARTER FINANCIAL RESULTS

BRIEF-Wright Medical Group Reports Q4 EPS $0.25 From Cont Ops

* WRIGHT MEDICAL GROUP N.V. REPORTS 2017 FOURTH QUARTER AND FULL-YEAR FINANCIAL RESULTS AND PROVIDES 2018 ANNUAL GUIDANCE

BRIEF-Wright Medical Group ‍Q4 Net Sales $218 Million​

* WRIGHT MEDICAL GROUP N.V. REPORTS 2017 FOURTH QUARTER AND FULL-YEAR FINANCIAL RESULTS AND PROVIDES 2018 ANNUAL GUIDANCE

BRIEF-Wright Medical Group buys IMASCAP SAS for $88.8 mln

* WRIGHT MEDICAL GROUP N.V. ANNOUNCES ACQUISITION OF IMASCAP SAS

BRIEF-Wright Medical Q3 loss per share $0.33 from continuing operations

* Wright medical group n.v. Reports 2017 third quarter financial results and updated 2017 annual guidance

BRIEF-Wright Medical Group ‍agreed on a comprehensive settlement intended to resolve substantially all remaining metal-on-metal hip claims

* Wright Medical Group - on October 3, co agreed on a comprehensive settlement intended to resolve substantially all remaining metal-on-metal hip claims

BRIEF-Wright Medical Group N.V. Q2 loss per share $0.20

* Wright Medical Group N.V. reports 2017 second quarter financial results

BRIEF-Wright Medical Group Q1 loss per share $0.35 from cont ops

* Wright Medical Group N.V. Reports 2017 first quarter financial results

BRIEF-Wright MEDICAL GROUP N.V. reports Q4 sales $193 million

* Wright Medical Group N.V. Reports 2016 fourth quarter and full-year financial results and provides 2017 guidance

BRIEF-Wright Medical Group announces entry into metal-on-metal hip litigation settlement agreement

* Wright Medical Group NV announces entry into metal-on-metal hip litigation settlement agreement Source text for Eikon: Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up